Veeva Vault CRM Selected by Eli Lilly and Company
Rhea-AI Summary
Veeva Systems (NYSE: VEEV) announced on August 11, 2026 that Eli Lilly and Company has committed to deploy Veeva Vault CRM globally. Vault CRM is part of the Vault CRM Suite, which Veeva describes as the technology foundation for agentic commercial, a new AI-enabled commercial model to help bring the right medicines to more patients.
Executives from Lilly and Veeva highlighted the expansion of their strategic relationship as Lilly rolls out Vault CRM worldwide. Investors are directed to Veeva’s risk disclosures and forward-looking statement cautions in its Form 10-Q for the fiscal year ended April 30, 2026.
Positive
- None.
Negative
- None.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Aug 05 | Earnings date notice | Neutral | +2.0% | Scheduled fiscal 2027 second-quarter results and conference call for August 26 |
| Jun 25 | Application launch | Positive | -2.0% | Introduced Veeva EHS for operational risk management and intelligent automation |
| Jun 23 | Acquisition and launch | Positive | +4.3% | Acquired Copli and launched Falcon MLR for content review |
| Jun 09 | Customer platform adoption | Positive | +0.3% | UCB unified global pharmacovigilance operations on Veeva Safety Suite |
| Jun 03 | Quarterly earnings report | Positive | -0.1% | Reported fiscal 2027 first-quarter revenue and updated full-year guidance |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Responses were mixed: three positive company updates preceded gains, while two company announcements preceded declines.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Vault CRM is part of the Vault CRM Suite of applications that provides the technology foundation for agentic commercial, the new commercial model that leverages AI to get the right medicines to more patients.
"We are excited to expand our strategic work with Veeva by moving to Vault CRM," said Giuseppe Firenze, senior vice president,
"Lilly creates medicines that make life better for people around the world," said Veeva CEO Peter Gassner. "We are proud to expand our strategic work with Lilly as they roll out Vault CRM globally."
Learn more about Veeva Vault CRM Suite, including the Agentic Call Report to generate Commercial Evidence, at veeva.com/crm.
About Veeva Systems
Veeva delivers the industry cloud for life sciences with applications, agents, data, and consulting. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,500 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.
Veeva Forward-Looking Statements
This release contains forward-looking statements regarding Veeva's products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the fiscal year ended April 30, 2026, which you can find here (a summary of risks which may impact our business can be found on pages 33 and 34), and in our subsequent SEC filings, which you can access at sec.gov.
Contact: | |
Maria Scurry | Meera Lakhani-Patel |
View original content to download multimedia:https://www.prnewswire.com/news-releases/veeva-vault-crm-selected-by-eli-lilly-and-company-302847385.html
SOURCE Veeva Systems